Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 155,000 | 28,000 | 153,000 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -11.6M | -12.6M | -4.7M |
| EBITDA | — | — | — |
| Net Income | -11.9M | -16.5M | -5.1M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 1M | 0M | 0M |
Silexion Therapeutics Corp. Income Statement — FAQ
Silexion Therapeutics Corp. (SLXN) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLXN's income statement history?
The chart and table above show Silexion Therapeutics Corp.'s income statement by year and by quarter, including the growth rate.